1. Certain existing stockholders, including TPG Global and members of SCA leadership, will sell 7 million shares of the company’s common stock.
2. The stock will be sold at a price of $33.25 per share.
3. A number of the selling stockholders have agreed to grant underwriters of the purchase the option to acquire up to 1.05 million additional shares of common stock at the public offering price.
4. The offering is expected to close on April 1.
5. Goldman, Sachs & Co.; Citigroup Global Markets and J.P. Morgan Securities are acting as joint book-running managers and representatives of the underwriters of the offering. Barclays Capital Inc., BofA Merrill Lynch, Deutsche Bank Securities Inc. and SunTrust Robinson Humphrey, Inc. are also acting as joint book-running managers for the offering. BMO Capital Markets Corp., TPG Capital BD, LLC and Morgan Stanley & Co. LLC are acting as co-managers for the offering.
More articles on transactions and valuation issues:
Surgery Partners prepares to file IPO
5 things to know about North Carolina’s CON reform bill
Study questions the efficacy of CON programs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.